Tebra vs Podium Review Response Automation Comparison 2027

Short answer: choose the category before the feature list

This tebra vs podium review response automation comparison turns on one category decision. Review response automation is software that drafts, routes or posts replies to online reviews, with a person approving each reply before it goes public. Tebra is a practice-management, EHR and billing platform that includes review replies in some of its bundles. Podium is a communication and reviews platform for local businesses, which a practice usually runs alongside a system it already has. Decide which of those jobs you are buying before you compare feature lists.

TL;DR: Tebra is the closer fit if you are choosing one system that also handles notes and billing, and only after the review feature is confirmed in writing for your bundle. Podium fits a practice that keeps its current EHR and wants a reviews and texting layer, and only after its BAA covers the workflow you plan. Neither vendor publishes base plan prices, so public pages cannot settle the cost question.

Key Takeaways

• Tebra and Podium are different categories: Tebra is practice management, EHR and billing, while Podium is messaging and reviews for local businesses.

• Neither vendor publishes base plan prices, so get one written quote per bundle before comparing cost.

• Tebra's own pages place review features in different bundles, so confirm which package includes AI review replies.

• Podium's industry menu names no healthcare or therapy category, and its BAA applies only to purchased services that involve protected health information.

• A public reply that confirms a reviewer is a client can be an impermissible disclosure under HIPAA, so the default reply should confirm nothing.

• Any automation should draft and log replies, with a named person approving each one before it posts.

What each company is, and who owns it

Ownership matters here because both companies have changed shape. Tebra exists because Kareo and PatientPop merged: according to HIT Consultant (2021), the merger closed on November 2, 2021, the combined company took the Tebra name, and it received $65M in growth financing from Golub Capital. Some third-party listings still carry the older names, so use the Tebra name on any contract.

Tebra announced a closed $250 million equity and debt financing in January 2026 according to Healthcare IT Today (2026). Hildred led the equity portion, and the stated purpose is accelerating AI and automation work, which includes the review tools covered below. I found no sale or change of control for Tebra in the sources reviewed.

Podium describes itself as "a communication and payments platform for local businesses." According to Futurum Group (2021), it closed a $201 million Series D in November 2021 at a valuation above $3 billion. That is the most recent round I could verify. I found no 2026 acquisition or change of control for Podium in the sources reviewed, so confirm ownership in writing if it matters to your contract.

In scope, Tebra sells its EHR, billing, telehealth and patient-experience features as bundles. Podium sells reviews, messaging and payments. The industry menu on Podium's reviews page lists auto dealerships, aesthetics, home services, retail, other and enterprise, with no healthcare or therapy category.

How we evaluated these tools

This is an informed buyer's guide built from public pages. It is not a hands-on trial, and neither vendor reviewed or shaped it. We weighted six criteria by what a small therapy owner actually decides on. Privacy and the BAA carry the most weight, because a single reply can disclose protected health information. The reply workflow comes next, because that is where staff time is saved or lost.

Table 1 gives the weights and the rubric. The rubric is for your own call: after you get written answers, score each vendor from 1 to 5 on each criterion. We did not assign either vendor a score here, because the public pages do not contain enough to score either one fairly.

Feature matrix: what the public pages say

The facts in Table 2 come from the pages cited in this guide. The last column is our analysis.

Vendor-reported early-adopter result: 81% more Google impressions according to AI Journal (2025). The same release places AI Review Replies inside EHR+ Patient Experience, and its early-adopter data comes with no sample size or timeframe.

Tebra's pricing page places Patient Feedback and Reviews in Practice Automation and Patient Experience + Marketing, not in EHR+. That mismatch is the question to settle in your quote: which bundle includes AI Review Replies, in writing.

Tebra's FAQ says a BAA is included in your agreement and names behavioral health and therapy practices as a target group. It also claims, according to Tebra, that its AI response suggestions save 90% of the time spent on review replies. Treat that as a vendor claim, not a measured result for your practice.

Podium's reviews product says its AI Reputation Specialist drafts review invites and replies, and it names Google and Facebook as review sites. Its pages do not say whether a reply posts automatically or waits for a person, so ask. The product also says it can automatically collect 5-star reviews via text. Asking only patients you expect to rate you highly can conflict with review-site policies, so check how the tool chooses who gets asked before you switch it on.

Review replies: where automation helps and where it breaks

Survey: 89% of consumers expect owners to respond according to BrightLocal (2026). The same survey found that 42% are unlikely to use a business that never replies, and that generic or templated replies put off 50% of consumers. It covers local businesses in general, not therapy practices, so treat it as direction rather than a benchmark for your practice.

Drafting helps with the time problem, not the judgment problem. Tebra's public description says staff give final approval before an AI reply goes live. Podium's AI Reputation Specialist drafts replies that can be customized. In both cases, the owner should approve every reply, because a draft cannot know whether the reviewer is a client, and a single wrong detail is the costly mistake.

US Tech Automations would treat this layer as a configurable workflow rather than a finished product. The design below is a proposal, not a description of a live deployment, and each step depends on prerequisites you would confirm first.

The first workflow starts with a trigger: a new review enters from the source you connect. With Podium, that source is the review object in Podium's API reference, which exposes fields such as review.rating, and Podium would need to confirm API access in writing before any build. With Tebra, the pages reviewed document import and export but not a review API, so a Tebra design would depend on an export Tebra confirms it can provide. The action sorts the review by star rating and checks whether the text mentions care, a clinician or a treatment. Reviews that name no one and mention no care get a draft from a pre-approved template that contains no patient information. Anything that mentions care goes to a human-only queue with no draft. The output is a draft in an approval queue, with a log showing who reviewed it and when. The human review point is simple: one named owner approves each reply, and nothing posts automatically.

The second workflow handles follow-up. The trigger is a draft that sits unapproved past the window the practice sets. The action reminds the named approver, then a named backup. The output is a weekly list of open reviews. Prerequisites include a secured notification channel, access controls that limit the queue to the staff who need it, and a BAA with any system in the chain that touches patient-linked data. The owner decides whether a late reply is sent, and the workflow never confirms that a reviewer is a client.

HIPAA: the reply is the disclosure risk

The HIPAA Journal's account of an OCR case notes that the Privacy Rule does not bar responding to reviews, but PHI cannot be disclosed online without the patient's written consent. Boston University's HIPAA FAQ answers whether a therapist should respond to a patient's review with "No," and it warns that a response "may be an impermissible disclosure of patient information and a violation of HIPAA and state privacy laws." According to Boston University, OCR has reached settlements with several providers over review responses.

OCR penalty: $30,000 for disclosing patient details in replies according to HIPAA Journal (2023). The case involved Manasa Health Center, a New Jersey provider of adult and child psychiatric services, whose replies to negative Google reviews disclosed four patients' protected health information. The corrective action plan required written HIPAA policies, workforce training, breach notification letters to the affected people and a breach report to OCR. OCR's director said, "Simply put, this is not allowed."

Podium publishes a Business Associate Agreement for covered entities. According to Podium (undated), it applies when a client gives Podium PHI in the course of using purchased Podium Services, requires written reports of impermissible uses or disclosures within 5 business days, and bars exporting PHI for storage outside the United States. The agreement does not list which features are covered or excluded, so ask Podium to name the review and text features in writing. Tebra's public copy says its AI replies "never include protected health information." That is a vendor statement, so get it into the contract rather than relying on the web page.

A safe default reply confirms nothing about the reviewer. It thanks the person, describes in general terms how the practice handles concerns, and invites them to contact the office directly. It never names a service, a date, a clinician or a treatment, even when the reviewer has already done so.

Pricing and total cost: what you can compare

Pricing checked November 13, 2026. Tebra's pricing page publishes no monthly or annual plan prices, and Podium's pricing page publishes no figures at all. Tebra's page names five bundles, Practice Automation, EHR+, Patient Experience + Marketing, EHR Starter and Billing Starter, and says you can request a personalized quote. Podium's page says its plans are "designed to fit your specific business needs" and directs you to sales.

Add-on pricing: about $75 per provider, one-time, for controlled-substance setup according to Tebra (2026); the same page lists a PDMP integration at $500 one-time per facility plus about $50 per user per year. Most therapists do not prescribe controlled substances, so those lines may not apply to you.

Table 3 uses only the Tebra pricing figures cited above. The year-one column is illustrative and assumes three clinicians.

The bundle question changes the math. If AI review replies sit in the marketing or patient-experience bundle, your comparison is a full system against a reviews layer, not a like-for-like add-on. Ask each vendor for one written quote per bundle, and compare the line that includes reviews.

What the math looks like for a three-clinician practice

Illustrative only, not a real customer: suppose a three-clinician practice receives 12 new Google reviews a month and spends about 6 minutes drafting each reply. That is 72 minutes a month, or 864 minutes (14.4 hours) a year. If a drafting tool cut that time by the 90% that Tebra's FAQ claims for AI suggestions, the practice would save about 13 hours a year (14.4 × 0.90 = 12.96), but it would still spend about 1.4 hours (14.4 × 0.10) reviewing and approving drafts, and the 90% is a vendor claim, not a result to plan on. On Podium, the review object documents a review.rating field on a 1 to 5 scale, so a rule could send 1- and 2-star reviews to a human-only queue, provided Podium confirms in writing that your account can read that field. Controlled-substance setup applies only when a clinician prescribes, and for three providers at $75 each it would be $225 one-time.

Vendor profiles: best fit, limits and evidence

Tebra

Best fit: a practice that needs an EHR, billing and reviews from one vendor, and that wants a platform naming behavioral health among its target groups. The limits are that base pricing is not public, that the AI reply feature is named for Google reviews, that Tebra's own pages do not settle which bundle includes it, that the FAQ does not mention an API, and that the early-adopter results come from Tebra's own release. Implementation means moving or confirming your records, billing and reviews together, so budget owner time for data mapping and staff training. The disqualifier is no written BAA, or no written confirmation of the bundle that includes AI review replies. Primary evidence is Tebra's pricing page, its FAQ and the press release reprinted by AI Journal, all cited above. Tebra suits a practice that is consolidating or replacing its system.

Podium

Best fit: a practice that keeps its current EHR and wants a reviews, texting and messaging layer. The limits are that its industry menu has no healthcare category, that it publishes no prices, that its BAA applies only to purchased services that involve PHI, that its pages do not say whether replies post automatically, and that its pages do not list EHR integrations. Reviews and texting touch patient contact data, so settle the BAA scope and the data flow before any import, and ask which features are HIPAA-enabled. Podium's pricing page says support, including onboarding, is included in every plan. The disqualifier is a BAA that does not cover the text and review features you plan to use. Primary evidence is Podium's BAA cited above and its review object reference, which documents review.rating, review.siteName and responses[].body.

Who this is for

This comparison fits an owner or operations lead at a small therapy practice who is close to choosing and needs to answer online reviews without disclosing anyone's information. It fits best when one named person can approve replies and when you can get written answers on bundles, the BAA and data export before signing.

Red flags: the vendor will not confirm in writing which bundle includes review replies; there is no written BAA covering the workflow; or the plan is to have the tool mention sessions, clinicians or diagnoses in replies.

The do-it-yourself alternative: Zapier, Make or n8n

Zapier, Make and n8n can run the same steps yourself. When configured, they can keep run histories, retries, error branches and audit evidence. The buyer still designs and owns what those tools do not decide for you: idempotency, so a retried step does not post a second reply; escalation when a step fails; access controls on the approval queue; and maintenance when a vendor changes its API. A proposed US Tech Automations design would differ mainly in what it configures up front, such as approval queues, no-patient-information templates and logs. It would not remove the prerequisites or the human review points described above, and the practice would still own the system after launch.

When NOT to use US Tech Automations. Skip this layer if your review volume is low enough that a manual reply with a generic template takes a few minutes a week, because a manual process is simpler to own. Skip it if you want one system for notes, scheduling and billing, since a practice-management platform already covers that and a workflow layer adds a second system to govern. Skip it if the vendor will not confirm API or export access or a BAA, because the design cannot run as proposed without them.

Common mistakes

• Comparing headline prices when neither vendor publishes base plan prices.

• Assuming AI replies are included because the feature appears on a marketing page.

• Letting a draft or template confirm that a reviewer is a client.

• Signing before the BAA scope is written down.

• Treating vendor percentages as results you will get.

• Starting automation with no named owner for missed approvals.

Terms used in this comparison

• Review response automation: software that drafts, routes or posts replies to online reviews.

• Protected health information (PHI): health information that identifies a person and that HIPAA protects.

• Business associate agreement (BAA): a contract under which a vendor that handles PHI accepts HIPAA obligations.

• Covered entity: a health care provider that bills electronically, a health plan, or a clearinghouse.

• Review gating: asking only patients you expect to rate you well to leave a review.

• EPCS: electronic prescribing of controlled substances.

• PDMP integration: a connection to a state prescription drug monitoring program.

• Human-in-the-loop approval: a named person reviews every draft before it posts.

Frequently asked questions

Is Tebra cheaper than Podium for a therapy practice?

Neither vendor publishes base plan prices, so public pages cannot show which is cheaper; get one written quote per bundle from each.

Does Tebra post review replies automatically?

Tebra's public description says staff give final approval before an AI reply goes live, so nothing should post without a person, but confirm that step for your bundle in writing.

Can a therapy practice use Podium under HIPAA?

Podium publishes a BAA for covered entities, but it applies to purchased services that involve PHI, so confirm in writing which review and text features it covers before any patient data enters the tool.

Should a therapy practice reply to reviews at all?

Responding is not barred outright, but the safe default is a generic reply that confirms nothing about the reviewer, because Boston University's FAQ says a response may be an impermissible disclosure.

Does Podium connect to my EHR?

Not confirmed: the pages reviewed name Google, Facebook and business-tool integrations and a marketplace, but no EHR list, so ask Podium for one before you assume a connection.

Which one should I choose?

Choose Tebra if you need an EHR, billing and reviews from one vendor and can confirm the bundle in writing; choose Podium if you keep your EHR, need a reviews and texting layer, and its BAA covers the workflow.

Conclusion

Tebra and Podium are not interchangeable. Tebra is the closer fit for a practice that wants one system for records, billing and reviews, with the review bundle confirmed in writing. Podium is the candidate for a practice that keeps its EHR and wants a reviews layer, but only once the BAA is in hand and its scope matches the workflow. If neither vendor will put the BAA, bundle and export terms in writing, the practical choice is to wait or keep replies manual. If you want to see how a review workflow would map to your own systems, see how US Tech Automations configures this before you sign anything.